When the levels of CaMkII and AMPK are reduced at the onset of neurodegenerative disease, the consequent reduced ability to express PGC-1α, FNDC5, BDNF, NGF, and GDNF could lead to cognitive dysfunction and deteriorating physical fitness [39]. This evidence concerns the gene PPARGC1A and neurodegenerative disease.